Friday, October 16, 2009
Biogen Idec Extends Offer For Facet Biotech To Dec 16 >FACT - Wall Street Journal
Biogen Idec Extends Offer For Facet Biotech To Dec 16 >FACT
Wall Street Journal
In after-hours trading, Facet shares were up 0.4% at $18.09, suggesting that Wall Street is expecting a higher offer from Biogen or another suitor. ...
and more »
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment